albuterol has been researched along with Airway Obstruction in 165 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Airway Obstruction: Any hindrance to the passage of air into and out of the lungs.
Excerpt | Relevance | Reference |
---|---|---|
"The pentosidine levels did not significantly differ between the two asthmatic subgroups with and without airway obstruction." | 9.16 | Association of airway pentosidine levels with bronchodilator response mediated by salbutamol administration in asthmatic patients. ( Hirata, K; Kanazawa, H; Tamagaki, G, 2012) |
"Aerosolised albuterol is an effective bronchodilator in horses with recurrent airway obstruction." | 9.15 | Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction. ( Bertin, FR; Couëtil, LL; Ivester, KM, 2011) |
"To determine the onset, magnitude, and duration of bronchodilation after administration of aerosolized salmeterol xinafoate in horses with recurrent airway obstruction." | 9.09 | Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction. ( Henrikson, SL; Rush, BR, 2001) |
"Twenty-one patients with chronic bronchitis and reversible airway obstruction participated in two single-blind, cross-over, placebo-controlled studies in inhaled clenbuterol - a new bronchodilator - and salbutamol." | 9.05 | A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction. ( Baronti, A; Grieco, A; Vibelli, C, 1980) |
"Indoramin, an alpha adrenoreceptor antagonist, was given in tablet form, in addition to regular salbutamol by aerosol, to 30 patients with airway obstruction." | 9.04 | Indoramin--an alpha adrenoreceptor antagonist for airway obstruction. ( Campbell, IA; Dyson, AJ, 1977) |
"Evaluation of the efficacy of nebulized magnesium sulfate (MgSO4) alone and in combination with salbutamol in acute asthma." | 7.83 | The efficacy of nebulized magnesium sulfate alone and in combination with salbutamol in acute asthma. ( Ali, MA; El-Garhy, OH; Sarhan, HA; Youssef, NA, 2016) |
"In patients with asthma, increased airway obstruction results in greater reductions in R(0) and Edyn after albuterol use." | 7.75 | Effects of airway obstruction on albuterol-mediated variations in the resistive and elastic properties of the respiratory system of patients with asthma. ( de Melo, PL; Jansen, JM; Lopes, AJ; Veiga, J, 2009) |
"Fifty children primarily with moderate-to-severe asthma were followed with measurements of urinary LTE(4), monitoring of FEV(1), and albuterol use." | 7.73 | Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction. ( Gelfand, EW; Rabinovitch, N; Zhang, L, 2006) |
"Inhaled acetaldehyde and adenosine 5'-monophosphate (AMP) cause bronchoconstriction in asthmatics by a mechanism believed to involve histamine release from airway mast cells." | 7.71 | Airway obstruction induced by inhaled acetaldehyde in asthma: repeatability relationship to adenosine 5'-monophosphate responsiveness. ( Cervera, A; Gutiérrez, V; Liñana, J; Prieto, L, 2002) |
"To determine whether pulmonary distribution of aerosolized technetium Tc 99m pentetate is improved after inhalation of a single dose of albuterol sulfate in horses susceptible to recurrent airway obstruction (heaves)." | 7.70 | Pulmonary distribution of aerosolized technetium Tc 99m pentetate after administration of a single dose of aerosolized albuterol sulfate in horses with recurrent airway obstruction. ( Davis, EG; Hakala, JE; Hoskinson, JJ; Matson, CJ; Rush, BR, 1999) |
"To determine the dose of aerosolized albuterol sulfate required to cause bronchodilation in horses with recurrent airway obstruction (RAO) and duration of this effect." | 7.70 | Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction. ( Berney, C; Derksen, FJ; Hakala, JE; Matson, CJ; Olszewski, MA; Robinson, NE; Ruth, DT, 1999) |
"Multiple aspects of lung function were measured in 17 cystic fibrosis (CF) patients on four occasions: without therapy (0); with oral theophylline medication (Th); after inhalation of salbutamol (beta 2); and with combined medication (Th + beta 2)." | 7.67 | Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics. ( Eber, E; Oberwaldner, B; Zach, MS, 1988) |
"Intravenous injections of aminophylline (250 mg) and tablets of theophylline (Neulin) (400 mg) were given, on separate occasions, to 10 patients with partially reversible severe airway obstruction." | 7.65 | Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction. ( Freitag, A, 1976) |
"Both procaterol and albuterol were highly effective in improving pulmonary function and controlling symptoms of asthma; both were well tolerated." | 6.67 | Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma. ( Mazza, JA; Reed, CE; Tashkin, DP, 1992) |
"Post hoc descriptive analysis of data stratified by FAO category (screening post-albuterol FEV1/FVC 5.19 | Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses. ( Chipps, BE; Tashkin, DP; Trudo, F; Zangrilli, JG, 2014) | |
"The pentosidine levels did not significantly differ between the two asthmatic subgroups with and without airway obstruction." | 5.16 | Association of airway pentosidine levels with bronchodilator response mediated by salbutamol administration in asthmatic patients. ( Hirata, K; Kanazawa, H; Tamagaki, G, 2012) |
"Aerosolised albuterol is an effective bronchodilator in horses with recurrent airway obstruction." | 5.15 | Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction. ( Bertin, FR; Couëtil, LL; Ivester, KM, 2011) |
"This study assessed the effect of the leukotriene receptor antagonist montelukast on hypertonic saline-induced airway obstruction." | 5.10 | Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD. ( Böhme, S; Jörres, RA; Kanniess, F; Magnussen, H; Nielsen-Gode, D; Richter, K; Zühlke, IE, 2003) |
"To determine the onset, magnitude, and duration of bronchodilation after administration of aerosolized salmeterol xinafoate in horses with recurrent airway obstruction." | 5.09 | Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction. ( Henrikson, SL; Rush, BR, 2001) |
"The efficacy and safety of orally administered procaterol hydrochloride, a potent beta 2-adrenergic bronchodilator, was compared with that of albuterol in an eight-center, double-blind study conducted in 223 patients with mild to moderate, reversible bronchial airway obstruction." | 5.06 | A comparison of oral procaterol and albuterol in reversible airflow obstruction. ( Beaupre, A; Boulet, LP; Brandon, ML; Busse, WW; Chervinsky, P; Mazza, J; Petty, TL; Schoenweter, W, 1988) |
"Metaproterenol (15 mg) and albuterol (5 mg) solutions were each nebulized and delivered to 20 patients with reversible airway obstruction utilizing intermittent positive pressure ventilation in a double-blind comparison." | 5.06 | A comparison of albuterol and metaproterenol nebulizer solutions. ( Campbell, SC; Habib, MP; Pinnas, JL; Shon, BY, 1987) |
"Twenty-one patients with chronic bronchitis and reversible airway obstruction participated in two single-blind, cross-over, placebo-controlled studies in inhaled clenbuterol - a new bronchodilator - and salbutamol." | 5.05 | A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction. ( Baronti, A; Grieco, A; Vibelli, C, 1980) |
"Indoramin, an alpha adrenoreceptor antagonist, was given in tablet form, in addition to regular salbutamol by aerosol, to 30 patients with airway obstruction." | 5.04 | Indoramin--an alpha adrenoreceptor antagonist for airway obstruction. ( Campbell, IA; Dyson, AJ, 1977) |
"The indications for heliox during mechanical ventilation are lower-airway obstruction, especially with hypercarbia; need to enhance aerosol delivery to lung periphery; and need to facilitate weaning from mechanical ventilation." | 4.83 | Heliox during mechanical ventilation. ( Venkataraman, ST, 2006) |
"Evaluation of the efficacy of nebulized magnesium sulfate (MgSO4) alone and in combination with salbutamol in acute asthma." | 3.83 | The efficacy of nebulized magnesium sulfate alone and in combination with salbutamol in acute asthma. ( Ali, MA; El-Garhy, OH; Sarhan, HA; Youssef, NA, 2016) |
"In patients with asthma, increased airway obstruction results in greater reductions in R(0) and Edyn after albuterol use." | 3.75 | Effects of airway obstruction on albuterol-mediated variations in the resistive and elastic properties of the respiratory system of patients with asthma. ( de Melo, PL; Jansen, JM; Lopes, AJ; Veiga, J, 2009) |
"Fifty children primarily with moderate-to-severe asthma were followed with measurements of urinary LTE(4), monitoring of FEV(1), and albuterol use." | 3.73 | Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction. ( Gelfand, EW; Rabinovitch, N; Zhang, L, 2006) |
"Inhaled acetaldehyde and adenosine 5'-monophosphate (AMP) cause bronchoconstriction in asthmatics by a mechanism believed to involve histamine release from airway mast cells." | 3.71 | Airway obstruction induced by inhaled acetaldehyde in asthma: repeatability relationship to adenosine 5'-monophosphate responsiveness. ( Cervera, A; Gutiérrez, V; Liñana, J; Prieto, L, 2002) |
"To determine whether pulmonary distribution of aerosolized technetium Tc 99m pentetate is improved after inhalation of a single dose of albuterol sulfate in horses susceptible to recurrent airway obstruction (heaves)." | 3.70 | Pulmonary distribution of aerosolized technetium Tc 99m pentetate after administration of a single dose of aerosolized albuterol sulfate in horses with recurrent airway obstruction. ( Davis, EG; Hakala, JE; Hoskinson, JJ; Matson, CJ; Rush, BR, 1999) |
"To determine the dose of aerosolized albuterol sulfate required to cause bronchodilation in horses with recurrent airway obstruction (RAO) and duration of this effect." | 3.70 | Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction. ( Berney, C; Derksen, FJ; Hakala, JE; Matson, CJ; Olszewski, MA; Robinson, NE; Ruth, DT, 1999) |
" Bronchial challenge tests were carried out with cumulative doses of inhaled carbachol in 10 healthy children (aged 7-14 yrs) and 50 asthmatic children (aged 5-15 yrs)." | 3.69 | Oscillatory pressure transients after flow interruption during bronchial challenge test in children. ( Frey, U; Kraemer, R, 1997) |
"We compared mood variables, symptom severity, albuterol use, and peak expiratory flow rate (PEFR) measured three times daily over a 21-day period in 21 adults with moderate to severe asthma." | 3.69 | Perception of airway obstruction in asthma: sequential daily analyses of symptoms, peak expiratory flow rate, and mood. ( Affleck, G; Apter, AJ; Barrows, E; Reisine, ST; Tennen, HA; Wells, M; Willard, A; ZuWallack, RL, 1997) |
"In guinea pigs passively sensitized to ovalbumin, sustained (6 days) subcutaneous infusion of (+/-)salbutamol (1 mg/kg/day) induced significant airway obstruction and heightened responsivity to airway spasmogens." | 3.68 | Exacerbation of airway hyperreactivity by (+/-)salbutamol in sensitized guinea pig. ( Hoshiko, K; Morley, J, 1993) |
" We conclude that smooth muscle contraction is important in A23187-induced airway obstruction; 5-hydroxytryptamine, thromboxane A2 and lipoxygenase products may be involved in maintaining this response; and that this approach is useful for investigating reversal of ongoing airway constriction." | 3.67 | Reversal of A23187-induced airway constriction in the guinea pig. ( Silbaugh, SA; Stengel, PW, 1989) |
" Inhalation of ovalbumin by sensitized guinea pigs induced three phases of airways obstruction: an early asthmatic response (EAR) peaking at 2 h, a late response (LAR) peaking at 17 h, and a further late response (LLAR) being observed at 72 h." | 3.67 | The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs. ( Church, MK; Holgate, ST; Hutson, PA, 1988) |
"Multiple aspects of lung function were measured in 17 cystic fibrosis (CF) patients on four occasions: without therapy (0); with oral theophylline medication (Th); after inhalation of salbutamol (beta 2); and with combined medication (Th + beta 2)." | 3.67 | Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics. ( Eber, E; Oberwaldner, B; Zach, MS, 1988) |
"Intravenous injections of aminophylline (250 mg) and tablets of theophylline (Neulin) (400 mg) were given, on separate occasions, to 10 patients with partially reversible severe airway obstruction." | 3.65 | Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction. ( Freitag, A, 1976) |
"Asthma and chronic obstructive pulmonary disease (COPD) are heterogeneous disorders encompassing different phenotypes of airflow obstruction, which might differ in their response to treatment." | 2.80 | Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults. ( Beasley, R; Bowles, D; Charles, T; Fingleton, J; Shirtcliffe, P; Strik, R; Travers, J; Weatherall, M; Williams, M, 2015) |
"Data on the onset of action of COPD medications are lacking." | 2.73 | Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. ( Lindberg, A; Pullerits, T; Radeczky, E; Szalai, Z, 2007) |
" Dose-response curves were compared using an analysis of covariance." | 2.69 | Tolerance to beta-agonists during acute bronchoconstriction. ( Aldridge, RE; Cowan, JO; Flannery, EM; Hancox, RJ; Herbison, GP; McLachlan, CR; Taylor, DR; Town, GI, 1999) |
" When parallel and linear cumulative dose-response curves were statistically compared on a logarithmic scale, the dose potency of salbutamol Turbuhaler vs salbutamol Diskhaler was 1." | 2.69 | Efficacy of cumulative doses of salbutamol administered via Turbuhaler or Diskhaler in patients with reversible airway obstruction. ( Arweström, E; Carlsson, LG; Friberg, K; Källén, A; Löfdahl, CG; Lunde, H, 1998) |
" Salmeterol was well tolerated as assessed by pulse, blood pressure, haematological and biochemical variables and number of adverse events." | 2.68 | The efficacy and safety of inhaled salmeterol 50 microg bd in older patients with reversible airflow obstruction. ( Luce, P; Starke, ID, 1996) |
"Finally, baseline airway obstruction correlated with the degree of bronchodilation achieved with MK-571 (r = -0." | 2.67 | Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. ( Bush, RK; Busse, WW; Gaddy, JN; Margolskee, DJ; Williams, VC, 1992) |
" After each period, dose-response curves were measured on 4 study days with doubling doses of salbutamol, ipratropium, a combination of salbutamol and ipratropium, and placebo until a plateau in FEV1 was reached." | 2.67 | Separate and combined effects of corticosteroids and bronchodilators on airflow obstruction and airway hyperresponsiveness in asthma. ( Alting-Hebing, D; Breederveld, N; Koëter, GH; Postma, DS; van der Mark, TW; Wempe, JB, 1992) |
"Both procaterol and albuterol were highly effective in improving pulmonary function and controlling symptoms of asthma; both were well tolerated." | 2.67 | Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma. ( Mazza, JA; Reed, CE; Tashkin, DP, 1992) |
" To determine whether these drugs also protect against excessive airway narrowing, the effect of inhaled salbutamol on the position and shape of the dose-response curves for histamine or methacholine was investigated in 12 patients with asthma and 11 with chronic obstructive lung disease." | 2.67 | The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. ( Bel, EH; Dijkman, JH; Sterk, PJ; Timmers, MC; Zwinderman, AH, 1991) |
"A double-blind, randomized crossover trial was carried out in 10 patients with reversible airways obstruction to assess dose-response and duration of action of 0." | 2.66 | A comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solutions assessing dose-response and duration of action. ( McIntosh, D, 1986) |
" Increase of dosage did not lead to improved effectiveness." | 2.65 | [Parasympathicolytic drugs in treatment of obstructive lung diseases (author's transl)]. ( Gonsior, E; Meier-Sydow, J; Schultze-Werninghaus, G, 1979) |
"Tremor was recorded with the higher doses of albuterol." | 2.64 | Albuterol and ephedrine in patients with reversible obstructive airway disease. ( Whitsett, TL, 1977) |
"Rimiterol is an acceptable alternative to the short-acting isoprenaline but lacks the cardiovascular effects of isoprenaline and is an alternative to salbutamol where very prolonged action is unnecessary." | 2.64 | Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol ('Pulmadil') and 0.2 mg. salbutamol. ( Bianco, S; Kamburoff, PL; Prime, FJ, 1975) |
"Status asthmaticus is a frequent cause of admission to a pediatric intensive care unit." | 2.49 | Pediatric status asthmaticus. ( Carroll, CL; Sala, KA, 2013) |
"The sensitivity of detecting airway obstruction in these children by FEV1 was 15." | 1.43 | Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma. ( Bar-Yoseph, R; Bentur, L; Hakim, F; Livnat, G; Ofek, M; Vilozni, D, 2016) |
"Airway obstruction was more severe in COPD patients as compared with controls (mean FEV1 and FEV1% predicted both P<0." | 1.43 | Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. ( Gálffy, G; Kováts, Z; Müller, V; Odler, B; Orosz, M; Selroos, O; Tamási, L, 2016) |
"We evaluated 21 patients with airway obstruction at the Department of Pulmonary Medicine, Samsun Medicalpark Hospital, Samsun, Turkey." | 1.40 | The relationship between early reversibility test and maximal inspiratory pressure in patients with airway obstruction. ( Bayrak, MG; Bostancı, O; Dirican, A; Ece, F; Karanfil, RC; Kaya, SO; Ozkaya, S, 2014) |
"COPD was likely the predominant diagnosis but patients with asthma may have been included." | 1.36 | Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity. ( Deesomchok, A; Forkert, L; Jensen, D; Lam, YM; O'Donnell, DE; Ofir, D; Webb, KA, 2010) |
"Airway emergencies were the most common emergencies seen in the offices." | 1.33 | Preparedness of selected pediatric offices to respond to critical emergencies in children. ( Gausche-Hill, M; Santillanes, G; Sosa, B, 2006) |
" Bronchial lability was characterized by (1) variability in mean daily peak expiratory flow rate and (2) bronchial responsiveness to either carbachol (as assessed by the threshold dose and the slope of the dose-response curve) or salbutamol (as assessed by the threshold dose and maximal response)." | 1.28 | Relationship between spontaneous dyspnoea and lability of airway obstruction in asthma. ( Lockhart, A; Marsac, J; Peiffer, C; Razzouk, H; Toumi, M, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 72 (43.64) | 18.7374 |
1990's | 41 (24.85) | 18.2507 |
2000's | 29 (17.58) | 29.6817 |
2010's | 23 (13.94) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gelb, AF | 1 |
Yamamoto, A | 1 |
Verbeken, EK | 1 |
Schein, MJ | 1 |
Moridzadeh, R | 1 |
Tran, D | 1 |
Fraser, C | 1 |
Barbers, R | 1 |
Elatre, W | 1 |
Koss, MN | 1 |
Glassy, EF | 1 |
Nadel, JA | 1 |
Rahmel, T | 1 |
Koniusch, A | 1 |
Schwertner, M | 1 |
Oprea, G | 1 |
Adamzik, M | 1 |
Nowak, H | 1 |
Johnson, J | 1 |
Johnson, SR | 1 |
Carroll, CL | 1 |
Sala, KA | 1 |
Yang, J | 1 |
Stanton, J | 1 |
Wang, L | 1 |
Beckert, L | 1 |
Frampton, C | 1 |
Burton, D | 1 |
Swanney, MP | 1 |
Tashkin, DP | 2 |
Chipps, BE | 1 |
Trudo, F | 1 |
Zangrilli, JG | 1 |
Ioan, I | 2 |
Coutier, L | 2 |
Bonabel, C | 2 |
Demoulin, B | 2 |
Marchal, F | 3 |
Schweitzer, C | 3 |
Varechova, S | 2 |
Maneechotesuwan, K | 1 |
Assawabhumi, J | 1 |
Rattanasaengloet, K | 1 |
Suthamsmai, T | 1 |
Pipopsuthipaiboon, S | 1 |
Udompunturak, S | 1 |
Ozkaya, S | 1 |
Dirican, A | 1 |
Kaya, SO | 1 |
Karanfil, RC | 1 |
Bayrak, MG | 1 |
Bostancı, O | 1 |
Ece, F | 1 |
Albrecht, J | 1 |
Fingleton, J | 1 |
Travers, J | 1 |
Williams, M | 1 |
Charles, T | 1 |
Bowles, D | 1 |
Strik, R | 1 |
Shirtcliffe, P | 1 |
Weatherall, M | 1 |
Beasley, R | 1 |
Hansen, M | 1 |
Meckler, G | 1 |
Lambert, W | 1 |
Dickinson, C | 1 |
Dickinson, K | 1 |
Guise, JM | 1 |
Müller, V | 1 |
Gálffy, G | 1 |
Orosz, M | 1 |
Kováts, Z | 1 |
Odler, B | 1 |
Selroos, O | 1 |
Tamási, L | 1 |
Neininger, MP | 1 |
Bertsche, T | 1 |
Sarhan, HA | 1 |
El-Garhy, OH | 1 |
Ali, MA | 1 |
Youssef, NA | 1 |
Vilozni, D | 1 |
Hakim, F | 1 |
Livnat, G | 1 |
Ofek, M | 1 |
Bar-Yoseph, R | 1 |
Bentur, L | 1 |
Sterner, JB | 1 |
Zanders, TB | 1 |
Morris, MJ | 1 |
Cancio, LC | 1 |
Angulo, M | 1 |
Taranto, E | 1 |
Soto, JP | 1 |
Malacrida, L | 1 |
Nin, N | 1 |
Hurtado, FJ | 1 |
Píriz, H | 1 |
Borrill, Z | 1 |
Roy, K | 1 |
Kolsum, U | 1 |
Southworth, T | 1 |
Vestbo, J | 2 |
Singh, D | 1 |
Veiga, J | 1 |
Lopes, AJ | 1 |
Jansen, JM | 1 |
de Melo, PL | 1 |
van Noord, JA | 1 |
Aumann, JL | 1 |
Janssens, E | 1 |
Smeets, JJ | 1 |
Zaagsma, J | 1 |
Mueller, A | 1 |
Cornelissen, PJ | 1 |
Deesomchok, A | 1 |
Webb, KA | 1 |
Forkert, L | 1 |
Lam, YM | 1 |
Ofir, D | 1 |
Jensen, D | 1 |
O'Donnell, DE | 1 |
Bertin, FR | 1 |
Ivester, KM | 1 |
Couëtil, LL | 1 |
Miranda, AD | 1 |
Valdez, TA | 1 |
Pereira, KD | 1 |
Dahlén, B | 1 |
Gómez, FP | 1 |
Casas, A | 1 |
Howarth, PH | 1 |
Dahlén, SE | 1 |
Rodriguez-Roisin, R | 1 |
Mackenzie, SD | 1 |
Blois, S | 1 |
Hayes, G | 1 |
Vince, AR | 1 |
Tamagaki, G | 1 |
Kanazawa, H | 1 |
Hirata, K | 1 |
Moreau-Colson, C | 1 |
Prieto, L | 1 |
Gutiérrez, V | 1 |
Cervera, A | 1 |
Liñana, J | 1 |
Saldien, V | 1 |
Coppejans, HC | 1 |
Vercauteren, MP | 1 |
Corthouts, B | 1 |
Van de Heyning, P | 1 |
Jorens, PG | 1 |
Silvestri, M | 1 |
Sabatini, F | 1 |
Sale, R | 1 |
Defilippi, AC | 1 |
Fregonese, L | 1 |
Battistini, E | 1 |
Biraghi, MG | 1 |
Rossi, GA | 1 |
Lindqvist, A | 1 |
Karjalainen, EM | 1 |
Laitinen, LA | 1 |
Kava, T | 1 |
Altraja, A | 1 |
Pulkkinen, M | 1 |
Halme, M | 1 |
Laitinen, A | 1 |
Cazzola, M | 1 |
Matera, MG | 1 |
Zühlke, IE | 1 |
Kanniess, F | 1 |
Richter, K | 1 |
Nielsen-Gode, D | 1 |
Böhme, S | 1 |
Jörres, RA | 1 |
Magnussen, H | 1 |
Robin, B | 1 |
Kim, YJ | 1 |
Huth, J | 1 |
Klocksieben, J | 1 |
Torres, M | 1 |
Tepper, RS | 1 |
Castile, RG | 1 |
Solway, J | 1 |
Hershenson, MB | 1 |
Goldstein-Filbrun, A | 1 |
Tomari, S | 1 |
Matsuse, H | 1 |
Machida, I | 1 |
Kondo, Y | 1 |
Kawano, T | 1 |
Obase, Y | 1 |
Fukushima, C | 1 |
Shimoda, T | 1 |
Kohno, S | 1 |
Silvanus, MT | 1 |
Groeben, H | 1 |
Peters, J | 1 |
Lødrup Carlsen, KC | 1 |
Pettersen, M | 1 |
Carlsen, KH | 1 |
Ezzahir, N | 1 |
Leske, V | 1 |
Peiffer, C | 2 |
Trang, H | 1 |
Bussamra, MH | 1 |
Cukier, A | 1 |
Stelmach, R | 1 |
Rodrigues, JC | 1 |
Tamura, G | 1 |
Suda, Y | 1 |
Thomas, MR | 1 |
Rafferty, GF | 1 |
Blowes, R | 1 |
Peacock, JL | 1 |
Marlow, N | 1 |
Calvert, S | 1 |
Milner, A | 1 |
Greenough, A | 1 |
Venkataraman, ST | 1 |
Zagdańska, R | 1 |
Grzelewska-Rzymowska, I | 1 |
Rabinovitch, N | 1 |
Zhang, L | 1 |
Gelfand, EW | 1 |
Santillanes, G | 1 |
Gausche-Hill, M | 1 |
Sosa, B | 1 |
Lindberg, A | 1 |
Szalai, Z | 1 |
Pullerits, T | 1 |
Radeczky, E | 1 |
Dyson, AJ | 2 |
Mackay, AD | 1 |
Packe, GE | 1 |
Cayton, RM | 1 |
Mashhoudi, N | 1 |
Kaik, G | 1 |
Kaik, B | 1 |
Laggner, A | 1 |
Firstater, E | 1 |
Mizrachi, E | 1 |
Topilsky, M | 1 |
Giulekas, D | 1 |
Tsakalos, N | 1 |
Christaki-Kukuriku, P | 1 |
Kotsopoulos, T | 1 |
Antoniou, D | 1 |
Carmichael, J | 1 |
Paterson, IC | 1 |
Diaz, P | 1 |
Crompton, GK | 2 |
Kay, AB | 1 |
Grant, IW | 1 |
Hughes, D | 1 |
Mindorff, C | 1 |
Levison, H | 1 |
Dalén, G | 1 |
Kjellman, B | 1 |
Emslander, HP | 1 |
Baronti, A | 1 |
Grieco, A | 1 |
Vibelli, C | 1 |
Surovov, IuA | 1 |
Sil'vestrov, VP | 1 |
Pakulin, IA | 1 |
Sahay, JN | 1 |
Chatterjee, SS | 1 |
Ormerod, LP | 1 |
Thomson, RA | 1 |
Anderson, CM | 1 |
Stableforth, DE | 1 |
Congleton, J | 1 |
Muers, MF | 1 |
Malo, JL | 1 |
L'Archevêque, J | 1 |
Ghezzo, H | 1 |
Cartier, A | 1 |
Fergusson, RJ | 1 |
Stewart, CM | 1 |
Wathen, CG | 1 |
Moffat, R | 1 |
Verberne, AA | 1 |
Hop, WC | 1 |
Bos, AB | 1 |
Kerrebijn, KF | 2 |
Hoshiko, K | 1 |
Morley, J | 1 |
Lundback, B | 1 |
Rawlinson, DW | 1 |
Palmer, JB | 1 |
Clough, JB | 1 |
Starke, ID | 1 |
Luce, P | 1 |
Malerba, M | 1 |
Boni, E | 1 |
Tantucci, C | 1 |
Filippi, B | 1 |
Romagnoni, G | 1 |
Grassi, V | 1 |
Frey, U | 2 |
Schibler, A | 1 |
Kraemer, R | 2 |
Emerman, CL | 1 |
Cydulka, RK | 1 |
Apter, AJ | 1 |
Affleck, G | 1 |
Reisine, ST | 1 |
Tennen, HA | 1 |
Barrows, E | 1 |
Wells, M | 1 |
Willard, A | 1 |
ZuWallack, RL | 1 |
Weersink, EJ | 1 |
van Zomeren, EH | 1 |
Koëter, GH | 2 |
Postma, DS | 2 |
Lin, RY | 1 |
Pesola, GR | 1 |
Westfal, RE | 1 |
Bakalchuk, L | 1 |
Freyberg, CW | 1 |
Cataquet, D | 1 |
Heyl, GT | 1 |
Ragg, MD | 1 |
Nour, MM | 1 |
Mustafa, KY | 1 |
Mousa, K | 1 |
Abul, AT | 1 |
Shuhaibar, H | 1 |
Yousif, AM | 1 |
Carlsson, LG | 1 |
Arweström, E | 1 |
Friberg, K | 1 |
Källén, A | 1 |
Lunde, H | 1 |
Löfdahl, CG | 2 |
Moy, ML | 1 |
Lantin, ML | 1 |
Harver, A | 1 |
Schwartzstein, RM | 1 |
Pellegrino, R | 1 |
Rodarte, JR | 1 |
Brusasco, V | 1 |
Mellén, A | 1 |
Arvidsson, P | 1 |
Palmqvist, M | 1 |
Lötvall, J | 1 |
Brand, PL | 1 |
Duiverman, EJ | 1 |
Waalkens, HJ | 1 |
van Essen-Zandvliet, EE | 1 |
Derksen, FJ | 1 |
Olszewski, MA | 1 |
Robinson, NE | 1 |
Berney, C | 1 |
Hakala, JE | 2 |
Matson, CJ | 2 |
Ruth, DT | 1 |
Rush, BR | 2 |
Hoskinson, JJ | 1 |
Davis, EG | 1 |
Walton, JS | 1 |
Fears, R | 1 |
Burt, N | 1 |
Dorman, BH | 1 |
Hancox, RJ | 1 |
Aldridge, RE | 1 |
Cowan, JO | 1 |
Flannery, EM | 1 |
Herbison, GP | 1 |
McLachlan, CR | 1 |
Town, GI | 1 |
Taylor, DR | 1 |
Fink, J | 1 |
Dhand, R | 1 |
Manthous, CA | 1 |
Lee, T | 1 |
Dennis, S | 1 |
Ziebach, R | 1 |
Pietsch-Breitfeld, B | 1 |
Bichler, M | 1 |
Busch, A | 1 |
Riethmüller, J | 1 |
Stern, M | 1 |
Henrikson, SL | 1 |
Marlin, GE | 3 |
Hartnett, BJ | 1 |
Berend, N | 2 |
Schultze-Werninghaus, G | 1 |
Gonsior, E | 1 |
Meier-Sydow, J | 1 |
Madsen, BW | 1 |
Tandon, MK | 1 |
Paterson, JW | 1 |
Patel, KR | 1 |
Kerr, JW | 2 |
Anderson, SD | 1 |
Silverman, M | 1 |
König, P | 2 |
Godfrey, S | 3 |
Gayrard, P | 1 |
Orehek, J | 1 |
Charpin, J | 1 |
Sly, RM | 1 |
Schindl, R | 1 |
Kamburoff, PL | 2 |
Prime, FJ | 3 |
Schmidt, OP | 1 |
Campbell, IA | 3 |
Whitsett, TL | 1 |
Simonsson, BG | 1 |
Arvidsson, I | 1 |
Haldeborg, M | 1 |
Månsson, A | 1 |
Webster, J | 1 |
Pierce, RJ | 1 |
Allen, CJ | 1 |
Campbell, AH | 1 |
Maneksha, S | 2 |
Knoop, U | 1 |
Nogrady, SG | 1 |
Evans, WV | 1 |
Davies, BH | 2 |
Baur, X | 1 |
Fruhmann, G | 1 |
Lidington, RE | 1 |
Cotton, DJ | 1 |
Graham, BL | 1 |
Dosman, JA | 1 |
Dash, CH | 3 |
McHardy, GJ | 2 |
Shotter, MV | 2 |
Cockcroft, DW | 1 |
Donevan, RE | 1 |
Copland, GM | 1 |
Perko, V | 1 |
Falaschi, C | 1 |
Rubin, AH | 1 |
Mansur, A | 1 |
Schey, G | 1 |
Shahor, Y | 1 |
Bruderman, I | 1 |
Freitag, A | 1 |
Spiro, SG | 1 |
Minette, A | 1 |
Petrie, GR | 1 |
Palmer, KN | 2 |
Bianco, S | 1 |
Radcliffe, S | 1 |
Seaton, A | 1 |
Graham, JD | 1 |
Toumi, M | 1 |
Razzouk, H | 1 |
Marsac, J | 1 |
Lockhart, A | 1 |
Flurkey, HG | 1 |
Gromova, OA | 1 |
Gusel', VA | 1 |
Waterhouse, JC | 1 |
Simmons, JL | 1 |
Wray, H | 1 |
Howard, P | 1 |
Gaddy, JN | 1 |
Margolskee, DJ | 1 |
Bush, RK | 1 |
Williams, VC | 1 |
Busse, WW | 2 |
Wempe, JB | 1 |
Breederveld, N | 1 |
Alting-Hebing, D | 1 |
van der Mark, TW | 1 |
Mazza, JA | 1 |
Reed, CE | 1 |
Derom, EY | 1 |
Pauwels, RA | 1 |
Weir, DC | 1 |
Sherwood Burge, P | 1 |
Dirksen, A | 1 |
Christensen, H | 1 |
Evald, T | 1 |
Jensen, BV | 1 |
Jensen, JI | 1 |
Keittelmann, S | 1 |
Kok-Jensen, A | 1 |
Bel, EH | 1 |
Zwinderman, AH | 1 |
Timmers, MC | 1 |
Dijkman, JH | 1 |
Sterk, PJ | 1 |
Tokuyama, K | 1 |
Lötvall, JO | 1 |
Barnes, PJ | 1 |
Chung, KF | 1 |
Hussein, A | 1 |
Harrie, K | 1 |
Kussau, D | 1 |
Riedler, J | 1 |
Vestri, R | 1 |
Philip-Joet, F | 1 |
Reynaud-Gaubert, M | 1 |
Arnaud, A | 1 |
Stengel, PW | 1 |
Silbaugh, SA | 1 |
Jenkins, C | 1 |
Breslin, AB | 1 |
Jorde, W | 1 |
Schata, M | 1 |
McIntosh, D | 1 |
Petty, TL | 1 |
Brandon, ML | 1 |
Chervinsky, P | 1 |
Schoenweter, W | 1 |
Beaupre, A | 1 |
Boulet, LP | 1 |
Mazza, J | 1 |
Deenstra, M | 1 |
Zanen, P | 1 |
Gusdorf, CF | 1 |
Hutson, PA | 1 |
Holgate, ST | 1 |
Church, MK | 1 |
Habib, MP | 1 |
Campbell, SC | 1 |
Shon, BY | 1 |
Pinnas, JL | 1 |
Eber, E | 1 |
Oberwaldner, B | 1 |
Zach, MS | 1 |
Couriel, JM | 1 |
Demis, T | 1 |
Olinsky, A | 1 |
Beardsmore, CS | 1 |
Maayan, C | 1 |
Bar-Yishay, E | 1 |
Gugger, M | 1 |
Crivelli, AM | 1 |
Galeazzi, RL | 1 |
Bachofen, H | 1 |
Noah, MS | 1 |
Kabiraj, MM | 1 |
Abdullah, AK | 1 |
Zaman, AU | 1 |
Skinner, C | 1 |
Cornia, G | 1 |
Gramiccioni, E | 1 |
Mannino, F | 1 |
McLeod, J | 1 |
Selman, J | 1 |
Dirksen, H | 1 |
Bülow, K | 1 |
Arborelius, M | 1 |
Lilja, B | 1 |
Epstein, SW | 2 |
Barnard, JA | 1 |
Zsotér, TT | 2 |
Poppius, H | 2 |
Salorinne, Y | 1 |
Cochrane, GM | 1 |
Clark, TJ | 1 |
Hanan, ME | 1 |
Harris, L | 1 |
Phelan, PD | 1 |
Stocks, JG | 1 |
Leinonen, L | 1 |
Muittari, A | 1 |
Lal, S | 1 |
Gribben, MD | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap[NCT03263130] | 60 participants (Anticipated) | Observational [Patient Registry] | 2017-01-01 | Recruiting | |||
Evaluation of Mechanism(s)Limiting Expiratory Airflow in Chronic, Stable Asthmatics Who Are Non-smokers[NCT01225913] | Phase 4 | 50 participants (Anticipated) | Interventional | 2007-10-31 | Recruiting | ||
Evaluation of Mechanism(s)Limiting Expiratory Airflow in Chronic, Stable Asthmatics Who Are Non-smokers[NCT00576069] | 60 participants (Anticipated) | Observational | 2007-10-25 | Recruiting | |||
A 12 Week, Randomized, Double-blind, Double-dummy, Placebo-controlled Trial of Symbicort TM (160/4.5mcg) Versus Its Mono-products (Budesonide and Formoterol) in Adolescents (at Least 12 Years of Age) and Adults With Asthma - SPRUCE 160/4.5[NCT00652002] | Phase 3 | 450 participants (Anticipated) | Interventional | 2002-07-31 | Completed | ||
Comparison of Doses of Nebulized Magnesium Sulphate as an Adjuvant Treatment With Salbutamol in Children With Status Asthmaticus[NCT04929626] | Phase 1 | 126 participants (Actual) | Interventional | 2022-01-01 | Completed | ||
Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated Large Artery Stiffness in COPD Patients[NCT03611699] | Phase 4 | 15 participants (Actual) | Interventional | 2019-01-24 | Completed | ||
Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma?[NCT01239199] | 86 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
Acute Bronchodilator Responsiveness in Obliterative Bronchiolitis (OB) Following Hematopoietic Stem Cell Transplantation[NCT01112241] | Phase 4 | 17 participants (Actual) | Interventional | 2010-04-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Following albuterol plus tiotropium inhalation, FEV1 increments ≥0.20 liters (L) as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to the American Thoracic Society-European Respiratory Society standard criteria [Pellegrino et al. Eur Respir J 2005; 26: 948-968]. They were calculated as follows: [FEV1 (L) after bronchodilators - FEV1 (L) before bronchodilators]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators
Intervention | absolute positive change (liters) (Mean) | |
---|---|---|
Responsives to bronchodilators (n=4) | Unresponsives to bronchodilators (n=13) | |
Albuterol Plus Tiotropium | 0.26 | 0.12 |
Following albuterol plus tiotropium inhalation, FVC increments ≥0.20 liters (L) compared with baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to the American Thoracic Society-European Respiratory Society standard criteria [Pellegrino et al. Eur Respir J 2005; 26: 948-968]. They were calculated as follows: [FVC (L) after bronchodilators - FVC (L) before bronchodilators]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators
Intervention | absolute positive change (liters) (Mean) | |
---|---|---|
Responsives to bronchodilators (n=5) | Unresponsives to bronchodilators (n=12) | |
Albuterol Plus Tiotropium | 0.65 | 0.07 |
Following albuterol plus tiotropium inhalation, FRC decrements ≥0.30 liters (L) as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to O'Donnell et al. [Eur Respir J 2001; 18: 914-920]. They were calculated as follows: [FRC (L), before bronchodilators - FRC (L) after bronchodilators]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators
Intervention | absolute negative change (liters) (Mean) | |
---|---|---|
Responsives to bronchodilators (n=4) | Unresponsives to bronchodilators (n=13) | |
Albuterol Plus Tiotropium | 0.78 | 0.07 |
Following albuterol plus tiotropium inhalation, RV decrements ≥0.30 liters (L) as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to O'Donnell et al. [Eur Respir J 2001; 18: 914-920]. They were calculated as follows: [RV (L), before bronchodilators - RV (L) after bronchodilators]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators
Intervention | absolute negative change (liters) (Mean) | |
---|---|---|
Responsives to bronchodilators (n=8) | Unresponsives to bronchodilators (n=9) | |
Albuterol Plus Tiotropium | 0.65 | 0.00 |
Following albuterol plus tiotropium inhalation, FEV1 increments ≥12 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to the American Thoracic Society-European Respiratory Society standard criteria [Pellegrino et al. Eur Respir J 2005; 26: 948-968]. They were calculated as follows: [FEV1, expressed in liters (L), after bronchodilators - FEV1 (L) before bronchodilators/FEV1 (L) before bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators
Intervention | per cent positive change (Mean) | |
---|---|---|
Responsives to bronchodilators (n=4) | Unresponsives to bronchodilators (n=13) | |
Albuterol Plus Tiotropium | 14 | 7 |
Following albuterol plus tiotropium inhalation, FVC increments ≥12 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to the American Thoracic Society-European Respiratory Society standard criteria [Pellegrino et al. Eur Respir J 2005; 26: 948-968]. They were calculated as follows: [FVC, expressed in liters (L), after bronchodilators - FVC (L) before bronchodilators/FVC (L) before bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators
Intervention | per cent positive change (Mean) | |
---|---|---|
Responsives to bronchodilators (n=5) | Unresponsives to bronchodilators (n=12) | |
Albuterol Plus Tiotropium | 24 | 2 |
Following albuterol plus tiotropium inhalation, FRC decrements ≥10 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to O'Donnell et al. [Eur Respir J 2001; 18: 914-920]. They were calculated as follows: [FRC, expressed in liters (L), before bronchodilators - FRC (L) after bronchodilators/FRC (L) after bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators
Intervention | per cent negative change (Mean) | |
---|---|---|
Responsives to bronchodilators (n=4) | Unresponsives to bronchodilators (n=13) | |
Albuterol Plus Tiotropium | 16 | 2 |
Following albuterol plus tiotropium inhalation, V'max increments ≥40 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to Pellegrino et al. [Chest 1998; 114:1607-1612]. They were calculated as follows: [V'max, expressed in liters.second-1 (L.s-1), after bronchodilators - V'max (L.s-1) before bronchodilators/V'max (L.s-1) before bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators
Intervention | per cent positive change (Mean) | |
---|---|---|
Responsives to bronchodilators (n=4) | Unresponsives to bronchodilators (n=13) | |
Albuterol Plus Tiotropium | 66 | 14 |
Following albuterol plus tiotropium inhalation, V'part increments ≥40 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to Pellegrino et al. [Chest 1998; 114:1607-1612]. They were calculated as follows: [V'part, expressed in liters.second-1 (L.s-1), after bronchodilators - V'part (L.s-1) before bronchodilators/V'part (L.s-1) before bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators
Intervention | per cent positive change (Mean) | |
---|---|---|
Responsives to bronchodilators (n=9) | Unresponsives to bronchodilators (n=8) | |
Albuterol Plus Tiotropium | 59 | 17 |
Following albuterol plus tiotropium inhalation, RV decrements ≥10 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to O'Donnell et al. [Eur Respir J 2001; 18: 914-920]. They were calculated as follows: [RV, expressed in liters (L), before bronchodilators - RV (L) after bronchodilators/RV (L) after bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators
Intervention | per cent negative change (Mean) | |
---|---|---|
Responsives to bronchodilators (n=8) | Unresponsives to bronchodilators (n=9) | |
Albuterol Plus Tiotropium | 19 | 0 |
7 reviews available for albuterol and Airway Obstruction
Article | Year |
---|---|
Pediatric status asthmaticus.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Airway Obstruction; Albuterol; Anti-Asthmatic A | 2013 |
Inflammatory mediators in smoke inhalation injury.
Topics: Adrenal Cortex Hormones; Airway Obstruction; Albuterol; Animals; Capillary Permeability; Heparin; Hu | 2009 |
Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPD.
Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Bronchodilator Agents; Dose-Response Relati | 2003 |
Heliox during mechanical ventilation.
Topics: Aerosols; Airway Obstruction; Albuterol; Bronchodilator Agents; Helium; High-Frequency Ventilation; | 2006 |
Bronchodilator resuscitation in the emergency department. Part 2 of 2: dosing strategies.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aerosols; Airway Obstruction; Albuterol; Asthm | 2000 |
Bronchodilation in mechanically ventilated patients: how much is enough and how best to deliver?
Topics: Administration, Inhalation; Aerosols; Airway Obstruction; Airway Resistance; Albuterol; Bronchoconst | 2000 |
Inhibition of exercise-induced asthma by different pharmacological pathways.
Topics: Adolescent; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Bronchodilator Agents; Chil | 1976 |
80 trials available for albuterol and Airway Obstruction
Article | Year |
---|---|
Evaluation of inhaled salbutamol effectiveness under supportive use of electrical impedance tomography in ventilated ICU patients: study protocol for a randomised controlled clinical trial.
Topics: Administration, Inhalation; Airway Obstruction; Albuterol; Bronchodilator Agents; Chronic Disease; C | 2019 |
Effect of salbutamol on the measurement of single-breath diffusing capacity.
Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Carbon Monoxide; Fema | 2013 |
Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses.
Topics: Adolescent; Adult; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Budesonide; Child; | 2014 |
Comparison between the effects of generic and original salmeterol/fluticasone combination (SFC) treatment on airway inflammation in stable asthmatic patients.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Cross- | 2014 |
Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Airway Obstruction; Albuterol; Anti-As | 2015 |
Seretide withdrawal increases airway inflammation in moderate COPD patients.
Topics: Aged; Airway Obstruction; Albuterol; Androstadienes; Drug Combinations; Fluticasone-Salmeterol Drug | 2009 |
Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms.
Topics: Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method | 2010 |
Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction.
Topics: Administration, Inhalation; Airway Obstruction; Albuterol; Animals; Bronchodilator Agents; Female; H | 2011 |
Salbutamol but not ipratropium abolishes leukotriene D4-induced gas exchange abnormalities in asthma.
Topics: Administration, Inhalation; Adult; Airway Obstruction; Albuterol; Arteries; Asthma; Bronchoconstrict | 2012 |
Association of airway pentosidine levels with bronchodilator response mediated by salbutamol administration in asthmatic patients.
Topics: Adult; Airway Obstruction; Albuterol; Arginine; Asthma; Biomarkers; Bronchial Provocation Tests; Bro | 2012 |
Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone propionate, and disodium cromoglycate.
Topics: Adult; Airway Obstruction; Albuterol; Androstadienes; Asthma; Biopsy; Bronchi; Cromolyn Sodium; Doub | 2003 |
Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Aged; Airway Obstruction; Albuterol; Bro | 2003 |
Pulmonary function in bronchopulmonary dysplasia.
Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Bronchopulmonary Dysplasia; Child, Preschool; | 2004 |
Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasm after tracheal intubation.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Aged; Airway Obstruction; Albuterol; Analysis o | 2004 |
Relevance of a portable spirometer for detection of small airways obstruction.
Topics: Administration, Inhalation; Adolescent; Airway Obstruction; Albuterol; Bronchodilator Agents; Child; | 2005 |
Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma.
Topics: Adolescent; Adult; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Bronchodilator Agents; | 2005 |
Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
Topics: Adrenal Cortex Hormones; Adult; Aged; Airway Obstruction; Albuterol; Androstadienes; Anti-Asthmatic | 2007 |
Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
Topics: Adolescent; Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Bronchodilator Agents; Clinical | 1980 |
[Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)].
Topics: Aerosols; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Drug Combinations; Ethanolami | 1980 |
The immediate effect of sodium cromoglycate on the airway.
Topics: Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Child; Cromolyn Sodium; Female; Humans | 1982 |
A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Bronchitis; Chronic Disease; Clenbuterol; Clinical Tr | 1980 |
A comparative trial of combination therapy in obstructive airways disease.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Aminophylline; Delayed-Action Preparations; Drug Therapy | 1980 |
The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Carcinoma, Bronchogenic; Drug Com | 1995 |
The reversibility of airway obstruction to an inhaled beta 2-adrenergic agent is less satisfactory after methacholine testing in asthmatic subjects.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchial Provocation Tests; Double-Blind Method | 1995 |
Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Ast | 1993 |
Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Asthma; Chemistry, Pharmaceutical; Double-Bl | 1993 |
The efficacy and safety of inhaled salmeterol 50 microg bd in older patients with reversible airflow obstruction.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Airway Obstruction; A | 1996 |
Ineffectiveness of intravenous beta 2-agonists on improving exercise tolerance in patients with reversible chronic airway obstruction.
Topics: Adrenergic beta-Agonists; Aged; Airway Obstruction; Albuterol; Blood Gas Analysis; Chronic Disease; | 1996 |
Effect of different albuterol dosing regimens in the treatment of acute exacerbation of chronic obstructive pulmonary disease.
Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volu | 1997 |
Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics.
Topics: Administration, Inhalation; Adult; Airway Obstruction; Albuterol; Androstadienes; Anti-Asthmatic Age | 1997 |
Early parenteral corticosteroid administration in acute asthma.
Topics: Acute Disease; Adult; Aerosols; Airway Obstruction; Albuterol; Anti-Asthmatic Agents; Anti-Inflammat | 1997 |
Reversible airway obstruction in rheumatic mitral valve disease.
Topics: Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volume; Human | 1998 |
Efficacy of cumulative doses of salbutamol administered via Turbuhaler or Diskhaler in patients with reversible airway obstruction.
Topics: Administration, Inhalation; Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Cross | 1998 |
Assessing the reversibility of airway obstruction.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Chronic Disease; Female; Humans; | 1998 |
Equivalent bronchodilation with salbutamol given via pMDI or turbuhaler.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Cross-Over Studies; Dose-Response | 1999 |
Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group.
Topics: Administration, Inhalation; Administration, Topical; Adolescent; Airway Obstruction; Albuterol; Anti | 1999 |
Tolerance to beta-agonists during acute bronchoconstriction.
Topics: Acute Disease; Adolescent; Adrenergic beta-Agonists; Adult; Airway Obstruction; Albuterol; Asthma; B | 1999 |
Bronchodilatory effects of salbutamol, ipratropium bromide, and their combination: double-blind, placebo-controlled crossover study in cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Airway Obstruction; Albuterol; Bronchodilat | 2001 |
Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction.
Topics: Administration, Inhalation; Airway Obstruction; Albuterol; Animals; Bronchodilator Agents; Cross-Ove | 2001 |
Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols.
Topics: Adult; Aerosols; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Catechols; Forced Expir | 1977 |
[Parasympathicolytic drugs in treatment of obstructive lung diseases (author's transl)].
Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Cromolyn Sodi | 1979 |
Cross-over study of the efficacy of four beta 2-sympathomimetic bronchodilator aerosols.
Topics: Adrenergic beta-Agonists; Adult; Aerosols; Aged; Airway Obstruction; Albuterol; Analysis of Variance | 1979 |
Letter: Alpha-receptor-blocking drugs in bronchial asthma.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Airway Obstruction; Airway Resistance; Albut | 1975 |
The bronchodilator effect of NAB 365.
Topics: Adult; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Clinical Trials as Topic; Ethan | 1977 |
Indoramin--an alpha adrenoreceptor antagonist for airway obstruction.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Clinical Trials as Topic; Drug Therapy, Combination; Fem | 1977 |
Albuterol and ephedrine in patients with reversible obstructive airway disease.
Topics: Airway Obstruction; Albuterol; Blood Pressure; Clinical Trials as Topic; Ephedrine; Forced Expirator | 1977 |
Treatment of airways obstruction by continuous nebulization with and without assisted ventilation.
Topics: Aged; Airway Obstruction; Albuterol; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Inte | 1977 |
Salbutamol by pressure-packed aerosol and by intermittent positive pressure ventilation in chronic obstructive bronchitis.
Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Bronchitis; Chronic Disease; Clinical Trials as Topic | 1978 |
A comparative study of atropine methonitrate, salbutamol, and their combination in airways obstruction.
Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Clinical Trials as Topi | 1979 |
A clinical trial of choline theophyllinate versus salbutamol with placebo control.
Topics: Administration, Oral; Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Choline; Cl | 1979 |
A comparative assessment of three bronchodilator preparations in general practice.
Topics: Airway Obstruction; Albuterol; Aminophylline; Delayed-Action Preparations; Humans; Peak Expiratory F | 1979 |
A comparative crossover study of two long-acting bronchodilator preparations.
Topics: Adult; Airway Obstruction; Albuterol; Aminophylline; Clinical Trials as Topic; Delayed-Action Prepar | 1976 |
Comparison of salmefamol and salbutamol in patients with chronic airways obstruction.
Topics: Adolescent; Adult; Airway Obstruction; Albuterol; Chronic Disease; Clinical Trials as Topic; Drug Ev | 1976 |
Carbuterol: a double-blind clinical trial comparing carbuterol and salbutamol.
Topics: Adult; Airway Obstruction; Albuterol; Asthma; Blood Pressure; Bronchitis; Bronchodilator Agents; Cli | 1976 |
Inhibition of exercise-induced asthma by different pharmacological pathways.
Topics: Adolescent; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Bronchodilator Agents; Chil | 1976 |
Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.
Topics: Aerosols; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Atropine; Atropine Derivatives; | 1975 |
Proceedings: Comparison of two bronchodilators--salmefamol and salbutamol.
Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Clinical Trials as Topic; Ethanolamines; Human | 1975 |
Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol ('Pulmadil') and 0.2 mg. salbutamol.
Topics: Adult; Aerosols; Airway Obstruction; Albuterol; Asthma; Blood Pressure; Bronchi; Bronchitis; Broncho | 1975 |
A trial of oral delta-1-(trans)-tetrahydrocannabinol in reversible airways obstruction.
Topics: Administration, Oral; Adult; Aged; Airway Obstruction; Albuterol; Animals; Blood Pressure; Bronchodi | 1975 |
Comparative assessment of a new breath-actuated inhaler in patients with reversible airways obstruction.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Asthma; Double-Blind Method; Forced Expiratory Volume; H | 1992 |
Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
Topics: Adult; Airway Obstruction; Albuterol; Analysis of Variance; Asthma; Double-Blind Method; Drug Therap | 1992 |
Separate and combined effects of corticosteroids and bronchodilators on airflow obstruction and airway hyperresponsiveness in asthma.
Topics: Adrenal Cortex Hormones; Adult; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Bronchial | 1992 |
Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Child; Dose-R | 1992 |
Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic.
Topics: Adolescent; Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Drug Administration Schedul | 1992 |
The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchoconstriction; Dose-Response Relationship, | 1991 |
[Effects of ipratropium bromide and salbutamol on isolated lung hyperinflation in symptom-free intervals in asthmatic children].
Topics: Administration, Inhalation; Adolescent; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; | 1990 |
[Inhalation bronchodilators in infancy--comparative study between salbutamol and ipratropium bromide].
Topics: Airway Obstruction; Albuterol; Atropine Derivatives; Female; Humans; Infant; Infant, Newborn; Ipratr | 1990 |
[The bronchodilator effect of aerosol beta-2-mimetic and anticholinergic agents in patients with chronic bronchitis].
Topics: Aerosols; Airway Obstruction; Albuterol; Bronchi; Bronchitis; Bronchodilator Agents; Chronic Disease | 1990 |
The role of alpha and beta adrenoceptors in airway hyperresponsiveness to histamine.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Airway Obstruction; Albutero | 1985 |
[Beta-2 specificity of bronchially active sympathomimetics using capillary laser Doppler sonography exemplified by tulobuterol].
Topics: Adrenergic beta-Agonists; Adult; Airway Obstruction; Albuterol; Double-Blind Method; Female; Humans; | 1987 |
A comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solutions assessing dose-response and duration of action.
Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Atropine Derivatives; Blood Pressure; Dose-Response R | 1986 |
A comparison of oral procaterol and albuterol in reversible airflow obstruction.
Topics: Administration, Oral; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Clinical Trials | 1988 |
Bronchospasmolytic effects of salbutamol as powder inhalation in patients with reversible bronchial obstruction.
Topics: Adult; Airway Obstruction; Albuterol; Bronchitis; Clinical Trials as Topic; Double-Blind Method; Fem | 1988 |
A comparison of albuterol and metaproterenol nebulizer solutions.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Clinical Trials as Topic; Double-Blind Method; Humans; I | 1987 |
Effects of the calcium antagonist tiapamil on pulmonary gas exchange in patients with chronic obstructive pulmonary disease who receive salbutamol.
Topics: Adult; Aged; Airway Obstruction; Albuterol; Double-Blind Method; Drug Evaluation; Drug Interactions; | 1985 |
A clinical trial of long-term oral salbutamol in reversible diffuse airway obstruction.
Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchitis; Chronic Disease; Clinica | 1973 |
Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis.
Topics: Aged; Airway Obstruction; Albuterol; Atropine; Bronchitis; Bronchodilator Agents; Chronic Disease; C | 1973 |
The role of oral bronchodilator therapy as shown by a comparison between salbutamol and terbutaline.
Topics: Administration, Oral; Adult; Airway Obstruction; Albuterol; Asthma; Blood Pressure; Clinical Trials | 1973 |
Comparison of cardiorespiratory effects of terbutaline and salbutamol aerosols in patients with reversible airways obstruction.
Topics: Adult; Aerosols; Aged; Airway Obstruction; Albuterol; Cardiac Output; Clinical Trials as Topic; Hear | 1973 |
A comparative trial of salbutamol and isoprenaline in asthma.
Topics: Adult; Aerosols; Airway Obstruction; Albuterol; Asthma; Carbon Dioxide; Female; Heart Rate; Humans; | 1974 |
79 other studies available for albuterol and Airway Obstruction
Article | Year |
---|---|
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent | 2018 |
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent | 2018 |
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent | 2018 |
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent | 2018 |
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent | 2018 |
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent | 2018 |
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent | 2018 |
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent | 2018 |
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent | 2018 |
Cross-sectional study of reversible airway obstruction in LAM: better evidence is needed for bronchodilator and inhaled steroid use.
Topics: Administration, Inhalation; Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Cross-Secti | 2019 |
Bronchial obstruction and reversibility in children: inspiratory or expiratory resistance?
Topics: Airway Obstruction; Albuterol; Asthma; Bronchial Diseases; Bronchodilator Agents; Case-Control Studi | 2014 |
The relationship between early reversibility test and maximal inspiratory pressure in patients with airway obstruction.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Bronchodilator Agents; Forced Expirat | 2014 |
Airway obstruction, upper airway artifact and response to bronchodilator in asthmatic and healthy children.
Topics: Airway Obstruction; Airway Resistance; Albuterol; Asthma; Bronchodilator Agents; Child; Female; Huma | 2015 |
Paramedic assessment and treatment of upper airway obstruction in pediatric patients: an exploratory analysis by the Children's Safety Initiative-Emergency Medical Services.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-2 Receptor Agonists; Airway Obstruction; Albu | 2016 |
Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
Topics: Administration, Inhalation; Aged; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Cros | 2016 |
[Risk reduction by pharmaceutical intervention. Medication management using the example of salbutamol].
Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Child; Humans; Medication Therapy Management; | 2016 |
The efficacy of nebulized magnesium sulfate alone and in combination with salbutamol in acute asthma.
Topics: Acute Disease; Administration, Inhalation; Airway Obstruction; Albuterol; Asthma; Double-Blind Metho | 2016 |
Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma.
Topics: Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Child; Child, Preschool; Female; Human | 2016 |
[Salbutamol improves diaphragmatic contractility in chronic airway obstruction].
Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Alkalosis; Animals; Chronic Disease; Diaphr | 2009 |
Effects of airway obstruction on albuterol-mediated variations in the resistive and elastic properties of the respiratory system of patients with asthma.
Topics: Adolescent; Adult; Aged; Airway Obstruction; Airway Resistance; Albuterol; Analysis of Variance; Ast | 2009 |
Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.
Topics: Aged; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Female; Humans; Lung Volume Meas | 2010 |
Bacterial tracheitis: a varied entity.
Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Bronchoscopy; Child; Exudates and Transudates; | 2011 |
Oral thermal injury associated with puncture of a salbutamol metered-dose inhaler in a dog.
Topics: Airway Obstruction; Albuterol; Animals; Burns; Dog Diseases; Dogs; Female; Metered Dose Inhalers; Mo | 2012 |
Respiratory impedance response to a deep inhalation in asthmatic children with spontaneous airway obstruction.
Topics: Adolescent; Airway Obstruction; Airway Resistance; Albuterol; Analysis of Variance; Asthma; Bronchod | 2002 |
Airway obstruction induced by inhaled acetaldehyde in asthma: repeatability relationship to adenosine 5'-monophosphate responsiveness.
Topics: Acetaldehyde; Adenosine Monophosphate; Administration, Inhalation; Adolescent; Adult; Airway Obstruc | 2002 |
Acute respiratory distress after upper airway obstruction following palatoplasty.
Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Child; Diuretics; Furosemide; Humans; Male; Pa | 2003 |
Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals.
Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Asthma; Breath Tests; Bronchodilator Agents | 2003 |
Three 20-minute interspaced salbutamol inhalations as a test for the diagnosis of reversible airflow limitation in adult asthmatics.
Topics: Administration, Inhalation; Administration, Oral; Aged; Airway Obstruction; Albuterol; Anti-Inflamma | 2004 |
Is bronchodilator response in 2-yr-old children associated with asthma risk factors?
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Airway Obstruction; Albuterol; Bronchodilator A | 2004 |
Images in clinical medicine. Airway dilatation after inhalation of a beta-agonist.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Airway Obstruction; Albuterol; Asthma; | 2005 |
Plethysmograph and interrupter resistance measurements in prematurely born young children.
Topics: Airway Obstruction; Airway Resistance; Albuterol; Bronchodilator Agents; Functional Residual Capacit | 2006 |
[FEV1 after three years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease].
Topics: Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Female; Follow-Up Studies | 2005 |
Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction.
Topics: Acetates; Adolescent; Airway Obstruction; Albuterol; Asthma; Child; Chronic Disease; Cyclopropanes; | 2006 |
Preparedness of selected pediatric offices to respond to critical emergencies in children.
Topics: Airway Obstruction; Albuterol; Anticonvulsants; California; Child; Child, Preschool; Data Collection | 2006 |
Nebulised ipratropium bromide and salbutamol causing closed-angle glaucoma.
Topics: Acute Disease; Aerosols; Aged; Airway Obstruction; Albuterol; Atropine Derivatives; Drug Therapy, Co | 1984 |
The effect of vagolytic drugs on airway obstruction in patients with bronchial asthma.
Topics: Airway Obstruction; Albuterol; Asthma; Atropine; Forced Expiratory Volume; Humans; Ipratropium; Maxi | 1981 |
Safety and efficacy of salbutamol aerosol on Dermatophagoides farinae induced bronchospasm in asthmatic patients.
Topics: Administration, Intranasal; Adolescent; Adult; Aerosols; Airway Obstruction; Albuterol; Antigens; As | 1984 |
Corticosteroid resistance in chronic asthma.
Topics: Adrenal Cortex Hormones; Adult; Airway Obstruction; Albuterol; Asthma; Bronchi; Chronic Disease; Cir | 1981 |
MMEF or FEV1 in estimating bronchial obstruction in asthmatic children.
Topics: Administration, Intranasal; Adolescent; Airway Obstruction; Albuterol; Asthma; Bronchospirometry; Ch | 1983 |
[Use of fiber bronchoscopy in emergency medicine].
Topics: Airway Obstruction; Albuterol; Beclomethasone; Bronchoscopy; Emergencies; Female; Fiber Optic Techno | 1980 |
[Significance of reversibility of obstructive respiratory disorders in bronchial asthma for prognosis of the effectiveness of treatment].
Topics: Aerosols; Airway Obstruction; Albuterol; Asthma; Humans; Prognosis | 1980 |
Reversible airway obstruction in cystic fibrosis.
Topics: Adolescent; Age Factors; Airway Obstruction; Albuterol; Asthma; Child; Child, Preschool; Cystic Fibr | 1980 |
Effectiveness of nebulised salbutamol administered in ambulances to patients with severe acute asthma.
Topics: Acute Disease; Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Airway Obstru | 1995 |
Exacerbation of airway hyperreactivity by (+/-)salbutamol in sensitized guinea pig.
Topics: Airway Obstruction; Albuterol; Animals; Bronchial Hyperreactivity; Guinea Pigs; Male; Ovalbumin; Res | 1993 |
Bronchodilators in infancy.
Topics: Airway Obstruction; Albuterol; Child, Preschool; Humans; Infant; Infant, Newborn; Respiratory Sounds | 1993 |
Pressure oscillations after flow interruption in relation to lung mechanics.
Topics: Adolescent; Adult; Airway Obstruction; Airway Resistance; Albuterol; Carbachol; Child; Humans; Lung; | 1995 |
Oscillatory pressure transients after flow interruption during bronchial challenge test in children.
Topics: Acoustics; Adolescent; Air; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Bronchial Prov | 1997 |
Perception of airway obstruction in asthma: sequential daily analyses of symptoms, peak expiratory flow rate, and mood.
Topics: Adolescent; Adult; Affect; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Female; Hum | 1997 |
Choking after inhaling a foreign body through a Ventolin puffer.
Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Foreign Bodies; Humans; Nebulizers and Vaporiz | 1998 |
Language of dyspnea in assessment of patients with acute asthma treated with nebulized albuterol.
Topics: Acute Disease; Administration, Inhalation; Adult; Airway Obstruction; Albuterol; Asthma; Bronchodila | 1998 |
Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction.
Topics: Administration, Inhalation; Aerosols; Airway Obstruction; Albuterol; Animals; Bronchodilator Agents; | 1999 |
Pulmonary distribution of aerosolized technetium Tc 99m pentetate after administration of a single dose of aerosolized albuterol sulfate in horses with recurrent airway obstruction.
Topics: Administration, Inhalation; Aerosols; Airway Obstruction; Albuterol; Animals; Bronchodilator Agents; | 1999 |
Intraoperative breathing circuit obstruction caused by albuterol nebulization.
Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Child; Epilepsy; Female; Humans; Hysterectomy; | 1999 |
Short-acting beta2-agonists.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Airway Obstruction; Albuterol; Asthma; Bro | 2000 |
Exercise-induced asthma.
Topics: Acidosis, Respiratory; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Airway Obstruction; Air | 1975 |
[Induced beta-adrenergic stimulation and blockade in asthma bronchomotor effects (author's transl)].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Airway Obstruction; Airway Resistance; Albute | 1975 |
Effect of beta-adrenoreceptor stimulants on exercise-induced asthma.
Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Asthma; Child; Epinephrine; Humans; Isoetha | 1975 |
[Broncholytic aerosols; with special attention to juvenile patients].
Topics: Adolescent; Aerosols; Age Factors; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Body He | 1978 |
[Management of severe asthma in childhood (author's transl)].
Topics: Acetylcysteine; Age Factors; Airway Obstruction; Albuterol; Aminophylline; Asthma; Bromhexine; Child | 1977 |
Reversibility of airways obstruction in bronchiectasis.
Topics: Adult; Airway Obstruction; Albuterol; Bronchiectasis; Female; Humans; Hypersensitivity; Male; Middle | 1978 |
[Pathogenesis and prevention of exercise-induced asthma].
Topics: Airway Obstruction; Albuterol; Asthma; Humans; Physical Exertion | 1978 |
Peripheral airways obstruction in patients with rhinitis.
Topics: Adult; Airway Obstruction; Albuterol; Female; Forced Expiratory Volume; Humans; Male; Maximal Midexp | 1979 |
[Clinical and functional aspects of obstructive respiratory syndromes following administration of a single dose of salbutamol in aerosol form].
Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Chronic Disease; Female; Humans; Male; Maximal Expira | 1977 |
Reversibility of small airway obstruction after therapy with salbutamol. Studies in asymptomatic asthmatic patients after inhalation of pressurized aerosol.
Topics: Adolescent; Adult; Aerosols; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Female; Force | 1977 |
Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction.
Topics: Adult; Airway Obstruction; Albuterol; Aminophylline; Chronic Disease; Female; Humans; Injections, In | 1976 |
Nocturnal asthma and sudden death.
Topics: Adolescent; Adult; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Circadian Rhythm; D | 1976 |
[Epidemiological contribution to the etiology of chronic bronchitis. III. Standardization of methods suitable for the study of bronchial hyperreactivity and allergy in epidemiology].
Topics: Acetylcholine; Airway Obstruction; Albuterol; Bronchial Diseases; Bronchitis; Bronchodilator Agents; | 1976 |
Relationship between spontaneous dyspnoea and lability of airway obstruction in asthma.
Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchi; Carbachol; Dyspnea; Female; | 1992 |
Albuterol.
Topics: Airway Obstruction; Albuterol; Bronchi; Drug Administration Schedule; Humans; Infant | 1992 |
[Study of circadian rhythm of bronchial patency for timely correction and evaluation of the effectiveness of inhalation powder forms of salbutamol in children with bronchial asthma].
Topics: Administration, Inhalation; Adolescent; Airway Obstruction; Albuterol; Asthma; Bronchi; Child; Circa | 1992 |
Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre.
Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volume; Humans; Ipra | 1991 |
Bronchodilator and corticosteroid reversibility in ambulatory patients with airways obstruction.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Dr | 1991 |
Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakage.
Topics: Administration, Inhalation; Airway Obstruction; Airway Resistance; Albuterol; Animals; Bronchodilato | 1991 |
Reversal of A23187-induced airway constriction in the guinea pig.
Topics: Airway Obstruction; Airway Resistance; Albuterol; Animals; Calcimycin; Dose-Response Relationship, D | 1989 |
The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs.
Topics: Airway Obstruction; Airway Resistance; Albuterol; Allergens; Animals; Asthma; Bronchi; Bronchoalveol | 1988 |
Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics.
Topics: Adolescent; Adult; Airway Obstruction; Albuterol; Child; Cystic Fibrosis; Drug Therapy, Combination; | 1988 |
The perception of asthma.
Topics: Adolescent; Airway Obstruction; Albuterol; Asthma; Child; Female; Forced Expiratory Volume; Humans; | 1986 |
Can thoracic gas volume be measured in infants with airways obstruction?
Topics: Airway Obstruction; Airway Resistance; Albuterol; Bronchiolitis, Viral; Cystic Fibrosis; Functional | 1986 |
Measurement of reversibility of airways obstruction: which parameters to use?
Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Child; Female; Forced Expiratory Volume; Hum | 1985 |
Bronchial asthma.
Topics: Adrenocorticotropic Hormone; Aerosols; Airway Obstruction; Albuterol; Aminophylline; Antigens; Asthm | 1974 |
Changes in specific airways conductance and forced expiratory volume in one second after a bronchodilator in normal subjects and patients with airways obstruction.
Topics: Administration, Oral; Adult; Aerosols; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Bro | 1974 |
[Treatment of bronchiolar obstruction].
Topics: Aerosols; Airway Obstruction; Albuterol; Asthma; Bronchial Diseases; Bronchial Spasm; Diagnosis, Dif | 1974 |
A comparison of Berotec (Th1165a) and Salbutamol aerosols.
Topics: Adult; Aerosols; Aged; Airway Obstruction; Albuterol; Blood Pressure; Bronchodilator Agents; Female; | 1973 |
Closing volume, spirometry and nitrogen wash-out in provoked asthma treated with salbutamol.
Topics: Adolescent; Adult; Airway Obstruction; Airway Resistance; Albuterol; Allergens; Asthma; Female; Huma | 1974 |
Effect of salbutamol on the peripheral circulation in man.
Topics: Adolescent; Adult; Aerosols; Aged; Airway Obstruction; Albuterol; Blood Circulation; Blood Pressure; | 1973 |
Management of severe viral bronchiolitis and severe acute asthma.
Topics: Acute Disease; Airway Obstruction; Albuterol; Aminophylline; Anti-Bacterial Agents; Asthma; Bronchio | 1974 |
An economical method of comparing inhaled bronchodilators in reversible diffuse airways obstruction. With special reference to a beta-2 stimulant--salmefamol.
Topics: Adult; Aerosols; Airway Obstruction; Albuterol; Analysis of Variance; Bronchodilator Agents; Ethanol | 1974 |